Proven to significantly reduce the clinical signs, severity, and spread of canine influenza infection1,12
Reduced the incidence and severity of coughing1
Decreased the overall clinical signs of disease, including ocular and nasal discharge, coughing, sneezing, depression, and dyspnea1
Reduced the days and amount of viral shedding1
Demonstrated protection against the formation and severity of lung lesions1
Contains killed (type A, subtype H3N8) virus combined with an adjuvant to enhance the immune response
This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine influenza virus.
NOBIVAC® CANINE FLU H3N8 IS A SAFE CHOICE
Safety confirmed through clinical use in more than 7 million dogs1
Well tolerated on subcutaneous administration
Proven safe across a multitude of dog breeds and ages
ADMINISTRATION AND DOSAGE
Two 1 mL doses given two to four weeks apart
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.